Reuters Market Eye - The BSE Sensex gains 0.22 percent, while the broader Nifty is up 0.32 percent on the back of gains in Sun Pharmaceutical Industries , which rose as much as 4 percent after a $3.2 billion deal to buy Ranbaxy Laboratories .
However, Ranbaxy shares lost as much as 3.2 percent on profit-taking. Ranbaxy shares had surged 32.6 percent in six consecutive sessions of gains till Friday's close.
Other blue-chips have also gained. Gail (India) Ltd up 2.1 percent and Larsen and Toubro up 1.2 percent.
Overseas investors bought Indian shares worth 2.32 billion rupees on Friday, provisional exchange data shows, while domestic institutional investors sold stocks worth 11.25 billion rupees.
(Reporting by Indulal P)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app